Companies celebrate new stem cell center as an alliance and recruitment catalyst
The recent DKK 2.2bn (USD 330m) grant the Novo Nordisk Foundation has allocated to a center focusing on stem cell treatments has been welcomed with open arms by pharmaceutical companies, who are jostling to enter the field.
by albert rønning andersson, translated by catherine brett and Daniel Frank Christensen
When Novo Nordisk announced that it was investing DKK 2.2bn (USD 330m) in an international stem cell center on Friday, this was music to the ears of many pharmaceutical companies.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
